We are live on ! Find out more
BCM

BIOS Capital Management Portfolio holdings

AUM $41.7M
1-Year Est. Return 34.92%
This Fund
S&P 500
This Quarter Est. Return
+5.74%
1 Year Est. Return
+34.92%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$94.1M
AUM Growth
–
Cap. Flow
+$96.6M
Cap. Flow %
102.67%
Top 10 Hldgs %
100%
Holding
6
New
6
Increased
–
Reduced
–
Closed
–
Avg Time Held
0 quarters
Top 10 Avg Time Held
0 quarters
Top 20 Avg Time Held
0 quarters

Top Buys

Rank Stock Value
1
ACTU icon
Actuate Therapeutics
ACTU
+$80.7M
2
RNTX icon
Rein Therapeutics
RNTX
+$5.12M
3
LTRN icon
Lantern Pharma
LTRN
+$4.14M
4
CGTX icon
Cognition Therapeutics
CGTX
+$2.97M
5
INAB icon
IN8bio
INAB
+$2.52M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
ACTU icon
1
Actuate Therapeutics
ACTU
$14.7M
$78.8M 83.69%
+9,893,651
New +$80.7M
2024 Q4
0 quarters
CGTX icon
2
Cognition Therapeutics
CGTX
$83.4M
$4.21M 4.47%
+6,000,000
New +$2.97M
2024 Q4
0 quarters
RNTX icon
3
Rein Therapeutics
RNTX
$68.5M
$3.89M 4.13%
+1,690,751
New +$5.12M
2024 Q4
0 quarters
LTRN icon
4
Lantern Pharma
LTRN
$12.1M
$3.85M 4.09%
+1,207,709
New +$4.14M
2024 Q4
0 quarters
INAB icon
5
IN8bio
INAB
$13.2M
$2.21M 2.35%
+286,667
New +$2.52M
2024 Q4
0 quarters
IRD icon
6
Opus Genetics
IRD
$387M
$1.18M 1.26%
+995,249
New +$1.14M
2024 Q4
0 quarters

Similar funds

BP
Baypointe Partners Stamford, Connecticut $41.7M AUM 18.93% 1-Year Est. Return
MAMNY
Marathon Asset Management (New York) New York $41.5M AUM 245.82% 1-Year Est. Return
AP
Atairos Partners Bryn Mawr, Pennsylvania $41.1M AUM 4.36% 1-Year Est. Return
CIC
Cincinnati Indemnity Company Fairfield, Ohio $41.1M AUM 6.63% 1-Year Est. Return
GCM
GuideStone Capital Management Dallas, Texas $42.5M AUM 41.03% 1-Year Est. Return
BCM
Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return
GC
Gruss & Co West Palm Beach, Florida $40.8M AUM 44% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return

BIOS Capital Management's Q4 2024 Portfolio in Review

Q4 2024 is the first quarter with a 13F filing on record for BIOS Capital Management, which disclosed 6 positions worth $94.1M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Actuate Therapeutics: 9,893,651 shares worth $78.8M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • BIOS Capital Management's largest Q4 2024 buy was Actuate Therapeutics: 9,893,651 shares worth $78.8M.
  • BIOS Capital Management's ten largest holdings make up 100% of its $94.1M portfolio in Q4 2024.
  • BIOS Capital Management disclosed 6 positions in Q4 2024, its first 13F filing on record.

Based on BIOS Capital Management's 13F filing for Q4 2024, filed 10 Feb 2025.